Ferreira, Adilson Kleber; Pasqualoto, Kerly Fernanda Mesquita; Kruyt, Frank A. E; Berl, Fanny Palace; Azevedo, Ricardo Alexandre de; Turra, Kely Medeiros; Rodrigues, Cecília Pessoa; Ferreira, Ana Carolina Franco; Salomon, Maria Alejandra Clavijo; Sá Júnior, Paulo Luiz de; Farias, Camyla Fernandes; Figueiredo, Carlos Rogério; Tavares, Leoberto Costa 
; Barbuto, José Alexandre Marzagão ; Jorge, Salomão Dória
Source: Toxicology and Applied Pharmacology. Unidades: FCF, ICB
Subjects: MELANOMA, METÁSTASE NEOPLÁSICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Adilson Kleber et al. BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity. Toxicology and Applied Pharmacology, v. 295, p. 56-67, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.taap.2016.02.008. Acesso em: 16 nov. 2024.APA
Ferreira, A. K., Pasqualoto, K. F. M., Kruyt, F. A. E., Berl, F. P., Azevedo, R. A. de, Turra, K. M., et al. (2016). BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity. Toxicology and Applied Pharmacology, 295, 56-67. doi:10.1016/j.taap.2016.02.008NLM
Ferreira AK, Pasqualoto KFM, Kruyt FAE, Berl FP, Azevedo RA de, Turra KM, Rodrigues CP, Ferreira ACF, Salomon MAC, Sá Júnior PL de, Farias CF, Figueiredo CR, Tavares LC, Barbuto JAM, Jorge SD. BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity [Internet]. Toxicology and Applied Pharmacology. 2016 ; 295 56-67.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.taap.2016.02.008Vancouver
Ferreira AK, Pasqualoto KFM, Kruyt FAE, Berl FP, Azevedo RA de, Turra KM, Rodrigues CP, Ferreira ACF, Salomon MAC, Sá Júnior PL de, Farias CF, Figueiredo CR, Tavares LC, Barbuto JAM, Jorge SD. BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity [Internet]. Toxicology and Applied Pharmacology. 2016 ; 295 56-67.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.taap.2016.02.008
